Hide

FocusBar

Subscribe to Premium Member
Free 7-day Trial
All Articles and Columns »

Further Proof: You Can't Believe Brokerage Research

August 30, 2012 | About:

Dr. Paul Price

36 followers
Brokerage analysts are always looking for an edge to show they offer "value-added" information. If you’re not paying strict attention you might think they did. Here’s yet another example of how the cheating occurs.

Sterne, Agee & Leach made a bold call early Wednesday morning. They predicted Jos. A. Bank (JOSB)'s earnings would rise and they loved the shares at the current $41.63 price. As Will Shakespeare’s Hamlet once said, “Ay, there’s the rub.”



As it turned out, JOSB had already reported, and Reuters had broadcast JOSB’s much better than expected earnings and same store sales. Their shares were up 13.5% in premarket trading.



JOSB had a gap opening at $48.00 – up $6.37 or 15.3% from Tuesday’s close. Nobody could buy the stock today at anywhere close to the price where Sterne, Agee & Leach will take credit for putting on their recommendation.

Anyone silly enough to act on their research blurb by buying at the open was down 1.17% by 4 p.m.

Why did Barron's lend their good name to this deceptive press release?

The day’s range was $47.29 to $49.48 with the intra-day low coming with just minutes to go. The chart speaks for itself.

About the author:

Dr. Paul Price: After college at The American University [BS - 1971] and dental school at University of Pennsylvania [DMD - 1977] Paul served as a dental officer in the United States Air Force both domestically and overseas in Turkey and England. In 1987 he made a full-time career switch by joining Merrill Lynch. Over the next 13 years he also worked with A.G. Edwards, Wheat First [now Wachovia Securities], and Ferris, Baker Watts. Dr. Price had enough success to retire in October 2000 but continues to help friends and family with their investments. He continues to give occasional investment seminars for civic groups and business schools.

Tickers in the article:

A Screener Endorsed by Warren Buffett without Knowing

In a recent interview Warren Buffett mentioned three companies that he finds attractive. Out of the three companies he mentioned, two of them are listed in GuruFocus’ Buffett-Munger screener. Buffett-Munger Screener looks for high quality companies that are traded at fair prices, the kind of companies that Buffett buys and hold forever. The Model Portfolio of Buffett-Munger Screener has outperformed the market year-over-year. It is just one of the features provided with GuruFocus Premium Membership.

Click Here to Try It Free!


Rating: 4.1/5 (20 votes)

Comments

superguru
Superguru - 9 months ago
But if analysts are making such big bucks, then some one is finding their work useful and paying for it. Correct?

Who are their clients?

Dr. Paul Price
Dr. Paul Price premium member - 9 months ago

The analysts' real clients are their employers. That's who pay them.

Fudging performance numbers makes them appear more successful and can lead to bigger salaries.
Cogitator99
Cogitator99 - 9 months ago
Good find.
motivator
Motivator - 9 months ago
Wow, average people being hustled by the powerful/better informed. I'm stunned! >.<

Please leave your comment:


More Gurufocus Links

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK

This article has been successfully added into your Bookmark.

Members Only. Please Sign Up or Log In first.

Bookmark of this article has been deleted.